Dr. Scott Douglas Newsome, DO

Dr. Newsome practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Newsome's NPI, 1326213265, was assigned on April 22, 2008. Dr. Newsome holds Maryland license NONE.

Dr. Newsome's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Newsome's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Newsome is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Newsome to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Newsome practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Newsome's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Newsome is licensed in Maryland.

CMS data shows 190 Medicare services from Dr. Newsome across 2 procedure codes in 2024, all of them office visits, for 153 Medicare patients. Medicare paid $21,292 for them.

CMS counts 153 Medicare patients who saw Dr. Newsome in 2024. The largest group is under 65, with 71 patients. 63% of them have high cholesterol, and 56% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Newsome's median patient age at 61, with 80% women.

In 2024, Dr. Newsome wrote 1,479 Medicare Part D claims for 113 patients. 63% of them were for generic drugs. CMS names the drug for 1,326 of them, across 26 drugs with 11 or more claims each, at $6,690,856 in total drug cost. In 2023, CMS named 1,203 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Newsome for performance year 2024, reported as part of a group. CMS lists Dr. Newsome as offering telehealth.

Dmand AI links 140 papers to Dr. Newsome, published from 2011 to 2025. 2023 was the busiest year, with 14. The most frequent topics are Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Stiff-Person Syndrome. Dr. Newsome has published most often in Neurol Neuroimmunol Neuroinflamm. Dr. Newsome's most frequent co-authors are Peter Arthur Calabresi, MD, Shiv Saidha, MBCHB and Yujie Wang, MD.

Dmand AI links Dr. Newsome to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis. Johns Hopkins University sponsors the most, 3.

CMS Open Payments shows 344 general payments to Dr. Newsome from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Genentech, Inc. paid the most, $115,805. It also lists 39 research payments totaling $86,228 from 2017 to 2025.